WallStreetZenWallStreetZen

NASDAQ: ODTX
Odyssey Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Odyssey Therapeutics revenue was N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ODTX annual revenue was $3.0M, with -33.5% growth year-over-year.

ODTX revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when ODTX announces revenue.

ODTX Revenue History By Year

ODTX Yearly RevenueODTX RevenueODTX ChangeODTX Revenue Growth
2025-12-31$2.98M-$1.50M-33.45%
2024-12-31$4.47MN/AN/A

1 of 1

Odyssey Therapeutics Revenue FAQ

What was ODTX's revenue last quarter?

On Sep 16, 2026, Odyssey Therapeutics (NASDAQ: ODTX) reported Q2 2026 revenue of $0.00 up 100% year over year. In the same quarter last year, Odyssey Therapeutics's revenue was $959.00 thousand.

What was Odyssey Therapeutics's revenue in 2025?

Odyssey Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $2.98 million, a 33.45% decrease year over year.

How much does Odyssey Therapeutics make in a day?

Based on Odyssey Therapeutics annual revenue for the past one years, ODTX makes an average of $8,153.42 per day.

What was Odyssey Therapeutics's annual revenue growth in the past year?

As of Q3 2026, Odyssey Therapeutics's revenue has grown null year over year. Odyssey Therapeutics's revenue in the past year totaled N/A.

How much does Odyssey Therapeutics make in a year?

Odyssey Therapeutics's revenue by year for the past one years is:
  • Odyssey Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $2.98 million, a 33.45% decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.